Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Super1nvestoron Sep 27, 2017 11:47pm

133 Views

Post# 26751820

RE:RE:RE:RE:RE:RE:RE:Base Shelf Prospectus

Guys, any PP is NOT good for the stock share price. Dilution is dilution no matter how you spin it. If they were smart, they'd take out a line of credit at a decent intetest rate, or get a bought deal done. Continuous PP's only fvck the value of the stock for ALL shareholders going forward. Why dilute? There are better ways to get the needed funding as i described above. Come on management, let's not shoot ourselves in the foot over and over again for no reason. Let's see if they smarten up at all.